MST1 and breast carcinoma: Loss of the TGF-β type II receptors in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-α–, macrophage-stimulating protein (MSP)– and hepatocyte growth factor (HGF)–mediated signaling networks.(31)